FIELD: biotechnology.
SUBSTANCE: vaccine contains an active substance and a target additive. As an active substance, the vaccine contains a mixture of attenuated purified antigenic material from Sheba strain of feline panleukopenia virus, Parvoviridae family, Protoparvovirus genus, Carnivore protoparvovirus 1 species, from inactivated and purified antigenic material from Pers strain of feline calicivirus, Caliciviridae family, Vesivirus genus, Feline calicivirus species, from inactivated and purified antigenic material from Fauna strain of feline calicivirus, Caliciviridae family, Vesivirus genus, Feline calicivirus species, from inactivated and purified antigenic material from Lavr strain of feline viral rhinotracheitis, Herpesviridae family, Varicellovirus genus, Alpaherpesvirus 1 species, as targeted additives: 3% aluminum hydroxide gel and stabilizer; taken in an effective ratio.
EFFECT: vaccine provides protective immune activity of each antigen in the body of dogs after administration of the target drug.
7 cl, 3 dwg, 6 tbl, 4 ex
